Cullinan Therapeutics Files 2025 Annual Report
Ticker: CGEM · Form: ARS · Filed: Apr 28, 2026 · CIK: 0001789972
| Field | Detail |
|---|---|
| Company | Cullinan Therapeutics, Inc. (CGEM) |
| Form Type | ARS |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, biotech
TL;DR
Cullinan Therapeutics filed its 2025 ARS. Check it for biz updates.
AI Summary
Cullinan Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 28, 2026, for the period ending December 31, 2025. The company, located at One Main Street, Suite 1350, Cambridge, MA 02142, is involved in Biological Products, excluding diagnostic substances.
Why It Matters
This filing provides shareholders with a comprehensive overview of the company's performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual filing providing historical information, not indicating immediate new risks.
Key Numbers
- 1637880 — Document Size (ARS PDF) (Size of the main annual report document in bytes.)
- 2257525 — Document Size (Text File) (Size of the complete submission text file in bytes.)
Key Players & Entities
- Cullinan Therapeutics, Inc. (company) — Filer of the ARS
- 0001789972 (company) — CIK number for Cullinan Therapeutics, Inc.
- 2026-04-28 (date) — Filing date of the ARS
- 2025-12-31 (date) — Period of report for the ARS
- ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 (address) — Mailing and Business Address for Cullinan Therapeutics, Inc.
FAQ
What is the primary business of Cullinan Therapeutics, Inc. according to this filing?
The company is primarily involved in Biological Products, excluding diagnostic substances, as indicated by its SIC code 2836.
When was the Annual Report to Security Holders (ARS) filed?
The ARS was filed on April 28, 2026.
What period does this ARS cover?
The period of report for this ARS is December 31, 2025.
What is the CIK number for Cullinan Therapeutics, Inc.?
The CIK number for Cullinan Therapeutics, Inc. is 0001789972.
Where is Cullinan Therapeutics, Inc. located?
The company's mailing and business address is ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 28, 2026 regarding Cullinan Therapeutics, Inc. (CGEM).